Table 1.
Cases | |||
---|---|---|---|
Variables | N | % | |
Sex | Male | 582 | 85.6 |
Female | 98 | 14.4 | |
Age at therapy initiation (years) | Median | 61 | |
Interquartile range | (56-67) | ||
Pathology grade | Well differentiated | 49 | 7.2 |
middle differentiated | 449 | 66.0 | |
Poorly differentiated | 166 | 24.4 | |
Undifferentiated | 2 | 0.3 | |
Missing | 14 | 2.1 | |
Depth of tumor | T1a-1b | 64 | 9.4 |
T2 | 131 | 19.3 | |
T3 | 485 | 71.3 | |
Lymph node metastasis | N0 | 296 | 43.5 |
N1 | 213 | 31.3 | |
N2 | 118 | 17.4 | |
N3 | 53 | 7.8 | |
Pathological stage | 1a-1b | 116 | 17.1 |
2a-2b | 229 | 33.7 | |
3a-3c | 335 | 49.3 | |
Vessel invasive | Yes | 210 | 30.9 |
No | 470 | 69.1 | |
Nerve infiltration | Yes | 254 | 37.4 |
No | 426 | 62.6 | |
Treatment regimen | S | 461 | 67.8 |
S plus postoperative C | 155 | 22.8 | |
S plus postoperative CRT | 64 | 9.4 | |
Hospital time after operation (days) | Median | 11 | |
Interquartile range | (10-14) | ||
LMR | Median | 3.17 | |
Interquartile range | (2.33-4.33) |
Abbreviations: S: surgery; C: chemotherapy; CRT: chemoradiotherapy; LMR: lymphocyte to monocyte ratio.